Streamlining the regulatory process for rare disease therapies could transform the treatment landscape. Learn more about the establishment of the FDA Center of Excellence for Rare Diseases and why it’s a crucial step toward addressing the unique regulatory challenges of rare diseases. EveryLife Foundation for Rare Diseases
🚨 Exciting News! The rare disease community just submitted a sign-on letter to Congress, with 100+ patient orgs and advocates touting the establishment of an FDA Rare Disease Center of Excellence in the 2025 approps bill. This center aims to streamline the regulatory process for rare disease therapies, bringing hope to millions affected by rare diseases. 🧬💪 Read the full letter and learn more about this initiative here: https://bit.ly/RDCOE #RareDisease #Advocacy #Healthcare #FDA #Congress #budget
